Drug archive
Calcitonin (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antihypercalcemic therapy adjunct - Calcitonin-Human; Calcitonin-Salmon
- Bone resorption inhibitor - Calcitonin-Human; Calcitonin-Salmon
- Osteoporosis therapy adjunct - Calcitonin-Human; Calcitonin-Salmon
Description
Calcitonin (kal-si-TOE-nin) is used to treat Paget's disease of bone. It also may be used to prevent continuing bone loss in women with postmenopausal osteoporosis and to treat hypercalcemia (too much calcium in the blood). This medicine may be used to treat other conditions as determined by your doctor.
Calcitonin is available only with your doctor's prescription, in the following dosage forms:
-
Calcitonin-Human
- Injection (U.S.)
-
Calcitonin-Salmon
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Calcimar 2
- Cibacalcin 1
- Miacalcin 2
In Canada -
- Calcimar 2
|
Note: |
For quick reference, the following calcitonin are numbered to match the corresponding brand names. |
| This information applies to the following medicines: | ||
| 1. | Calcitonin-Human (kal-si-TOE-nin HYOO-man)† | |
| 2. | Calcitonin-Salmon (kal-si-TOE-ninSAM-en) | |
| † Not commercially available in Canada | ||